We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$15.9B
AUM Growth
+$1.24B
Cap. Flow
+$523M
Cap. Flow %
3.3%
Top 10 Hldgs %
35.05%
Holding
1,298
New
139
Increased
794
Reduced
319
Closed
45

Sector Composition

Rank Sector Weight
1 Technology 33.02%
2 Financials 19.16%
3 Energy 5.34%
4 Healthcare 4.01%
5 Industrials 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTIL icon
801
Precision BioSciences
DTIL
$181M
$1.28M 0.01%
3,404
-6,025
-64% -$1.81M
MCD icon
802
McDonald's
MCD
$191B
$1.28M 0.01%
5,523
+118
+2% +$27.5K
KMX icon
803
CarMax
KMX
$8.33B
$1.27M 0.01%
9,867
+3,248
+49% +$402K
BSX icon
804
Boston Scientific
BSX
$68.4B
$1.26M 0.01%
29,412
+2,671
+10% +$112K
FRME icon
805
First Merchants
FRME
$2.69B
$1.25M 0.01%
29,978
+6,488
+28% +$296K
SBCF icon
806
Seacoast Banking Corp of Florida
SBCF
$3.35B
$1.25M 0.01%
36,541
+3,566
+11% +$130K
WM icon
807
Waste Management
WM
$90.9B
$1.25M 0.01%
8,908
+1,209
+16% +$167K
ANAB icon
808
AnaptysBio
ANAB
$1.63B
$1.24M 0.01%
47,963
-42,840
-47% -$1.03M
FIBK icon
809
First Interstate BancSystem
FIBK
$3.74B
$1.24M 0.01%
29,702
+633
+2% +$29.2K
SC
810
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$1.24M 0.01%
34,128
-2,126
-6% -$73.8K
CTMX icon
811
CytomX Therapeutics
CTMX
$714M
$1.24M 0.01%
195,286
+32,629
+20% +$254K
ETN icon
812
Eaton
ETN
$150B
$1.23M 0.01%
8,328
+1,450
+21% +$209K
BKE icon
813
Buckle
BKE
$2.27B
$1.23M 0.01%
24,710
+6,806
+38% +$289K
SASR
814
DELISTED
Sandy Spring Bancorp Inc
SASR
$1.23M 0.01%
27,791
+7,429
+36% +$337K
EGBN icon
815
Eagle Bancorp
EGBN
$838M
$1.23M 0.01%
21,839
+4,506
+26% +$249K
TSCO icon
816
Tractor Supply
TSCO
$15.8B
$1.22M 0.01%
32,655
+7,160
+28% +$262K
BECN
817
DELISTED
Beacon Roofing Supply, Inc.
BECN
$1.21M 0.01%
22,719
+3,060
+16% +$171K
BBT
818
Beacon Financial Corp
BBT
$2.57B
$1.21M 0.01%
44,108
-4,305
-9% -$109K
HCA icon
819
HCA Healthcare
HCA
$85.7B
$1.21M 0.01%
5,845
+362
+7% +$73.8K
EMR icon
820
Emerson Electric
EMR
$83.3B
$1.21M 0.01%
12,532
+1,610
+15% +$151K
ULTA icon
821
Ulta Beauty
ULTA
$22.2B
$1.2M 0.01%
3,465
+769
+29% +$252K
SYF icon
822
Synchrony
SYF
$25.1B
$1.2M 0.01%
24,642
+3,617
+17% +$165K
PCVX icon
823
Vaxcyte
PCVX
$8.08B
$1.19M 0.01%
52,906
-37,877
-42% -$775K
RNAM
824
DELISTED
Avidity Biosciences
RNAM
$1.19M 0.01%
48,196
-12,508
-21% -$291K
PMVP icon
825
PMV Pharmaceuticals
PMVP
$60.3M
$1.19M 0.01%
34,714
+8,242
+31% +$275K

Similar funds

Rafferty Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Rafferty Asset Management held 1,298 positions worth $15.9B, up 8.5% from $14.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rafferty Asset Management deployed $523M of net new capital in Q2 2021, opening 139 new positions and adding to 794 existing holdings. Its largest new stake was Blackstone: 386,473 shares worth $37.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $197M trimmed.

  • Rafferty Asset Management's largest Q2 2021 buy was Blackstone: 386,473 shares worth $37.5M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $228M increase.
  • Rafferty Asset Management's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $197M.
  • Rafferty Asset Management fully exited A10 Networks in Q2 2021, selling an estimated $258M.
  • Rafferty Asset Management's ten largest holdings make up 35% of its $15.9B portfolio in Q2 2021.
  • Rafferty Asset Management opened 139 new positions and closed 45 in Q2 2021.
  • Rafferty Asset Management's portfolio value rose 8.5% quarter-over-quarter to $15.9B.

Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.